Email Updates Archive

Stay in touch with ACCRF and learn about the newest advances in ACC research by signing up to receive our email updates. You can expect to receive one email update per quarter.
12.20.12 - ACCRF Year End Letter
Highlights from a remarkable year include a third Dovitinib clinical trial, $8 million in NIH grants and a revamped website.
09.20.12 - 3rd Workshop on Salivary Gland Tumors
The re-invigoration of the field of salivary gland tumor research over the past 6 years has been a very welcome...
02.03.12 - Dovitinib Study Opens at the University of Virginia
The University of Virginia has begun screening ACC patients with progressive disease for a new clinical trial. Supported by Novartis...
01.09.12 - RFAs for Salivary Gland Tumor Research
The National Institute of Dental and Craniofacial Research (NIDCR) posted two Requests for Applications (RFAs) seeking grant proposals to enhance...
12.21.11 - ACCRF Year End Letter (2011)
Your support made 2011 a banner year! And together we can do even more in 2012! Your generosity and the...
07.26.11 - Update on Progressive ACC
ACC Patients with tumors that are clearly growing face a journey with few signposts. This update provides information on treatment...
11.18.10 - Guide to Systemic Therapy
ACC patients dealing with progressive disease face many uncertainties. This guide for patients and physicians provides context and information for...
11.17.10 - ACC Patient Community Survey
ACCRF and ACCOI conducted a joint survey of the ACC patient community to gauge the priorities, communication preferences and volunteering...
08.21.10 - ACCRF Accomplishments
The pace of research progress in ACC has quickened over the past two years, providing the patient community with justifiable...
02.01.10 - Scientific Advisory Board Update
ACCRF convened a meeting of its Scientific Advisors to review recent research findings and to explore the implications of the...